COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,024 Articles (22,627 medRxiv, 8,397 bioRxiv)

Most recent first Previous |  Page 979: Articles 9781-9790  | Next

Infectious viral load in unvaccinated and vaccinated patients infected with SARS-CoV-2 WT, Delta and Omicron
Puhach, O., Adea, K., Hulo, N., Sattonnet-Roche, P., Genecand, C., Iten, A., Jacquerioz Bausch, F., Kaiser, L., Vetter, P., Eckerle, I., Meyer, B.
10.1101/2022.01.10.22269010 — Posted: 2022-01-11 Discussion: Onsite
Real World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 Outpatients
Wynia, M. K., Beaty, L. E., Bennett, T. D., Carlson, N. E., Davis, C. B., Kwan, B. M., Mayer, D. A., Ong, T. C., Russell, S., Steele, J., Stocker, H. R., Wogu, A. F., Zane, R. D., Sokol, R. J., Ginde, A. A.
10.1101/2022.01.09.22268963 — Posted: 2022-01-11
Longitudinal symptom and clinical outcome analysis of hospitalized COVID-19 patients
Ziemys, A.
10.1101/2022.01.11.22268908 — Posted: 2022-01-11
COVID-19 Time of Intubation Mortality Evaluation (C-TIME): A System for Predicting Mortality of Patients with COVID-19 Pneumonia at the Time They Require Mechanical Ventilation.
Raschke, R. A., Rangan, P., Agarwal, S., Uppalapu, S., Sher, N., Curry, S. c., Hesie, C. W.
10.1101/2022.01.09.22268977 — Posted: 2022-01-11
SARS-CoV-2 triggers complement activation through interactions with heparan sulfate
Lo, M. W., Amarilla, A. A., Lee, J. D., Albornoz, E. A., Modhiran, N., Clark, R. J., Ferro, V., Chhabra, M., Khromykh, A. A., Watterson, D., Woodruff, T. M.
10.1101/2022.01.11.475820 — Posted: 2022-01-11
A single-cell atlas reveals shared and distinct immune responses and metabolism during SARS-CoV-2 and HIV-1 infections
Pan, T., Cao, G., Tang, E., Zhao, Y., Penaloza-MacMaster, P., Fang, Y., Huang, J.
10.1101/2022.01.10.475725 — Posted: 2022-01-11
The impact of post-hospital remote monitoring of COVID-19 patients using pulse oximetry: a national observational study using hospital activity data
Georghiou, T., Sherlaw-Johnson, C., Massou, E., Morris, S., Crellin, N. E., Herlitz, L., Sidhu, M. S., Tomini, S. M., Vindrola-Padros, C., Walton, H., Fulop, N. J.
10.1101/2022.01.11.22269068 — Posted: 2022-01-11
The incidence and mortality of COVID-19 related TB infection in Sub-Saharan Africa: A systematic review and meta-analysis
Tamuzi, J. J., Lulendo, G., Mbuesse, P.
10.1101/2022.01.11.22269065 — Posted: 2022-01-11
COVID-19 vaccination breakthrough infections in a real-world setting: Using community reporters to evaluate vaccine effectiveness
Reynolds, M. W., Xie, Y., Knuth, K. B., Mack, C. D., Brinkley, E., Toovey, S., Dreyer, N. A.
10.1101/2022.01.11.22268736 — Posted: 2022-01-11
Systematic review and meta-analysis of COVID-19 vaccines safety, tolerability, and efficacy among HIV-infected patients
Tamuzi, J. J., Muyaya, L. M., Mitra, A., Nyasulu, P.
10.1101/2022.01.11.22269049 — Posted: 2022-01-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).